Enhabit (NYSE:EHAB) Lowered to “Hold” at Jefferies Financial Group

Enhabit (NYSE:EHAB) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued on Thursday, FinViz reports. They presently have a $8.75 price target on the stock, down from their previous price target of $14.00. Jefferies Financial Group’s target price indicates a potential downside of 9.70% from the company’s previous close.

EHAB has been the subject of several other research reports. Oppenheimer reaffirmed a “market perform” rating on shares of Enhabit in a research report on Thursday, March 7th. UBS Group raised shares of Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 price objective for the company in a research note on Thursday, March 7th. Two investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat, Enhabit currently has an average rating of “Hold” and a consensus price target of $11.21.

Enhabit Stock Down 2.1 %

EHAB stock opened at $9.69 on Thursday. The business’s 50 day simple moving average is $10.39 and its 200 day simple moving average is $10.03. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $486.05 million, a PE ratio of -5.98, a PEG ratio of 1.56 and a beta of 1.98. Enhabit has a 1-year low of $7.12 and a 1-year high of $14.59.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, March 6th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.01. The firm had revenue of $260.60 million for the quarter, compared to analyst estimates of $260.30 million. Enhabit had a positive return on equity of 1.55% and a negative net margin of 7.69%. During the same period in the prior year, the firm posted $0.32 EPS. As a group, research analysts anticipate that Enhabit will post 0.24 EPS for the current year.

Institutional Trading of Enhabit

Institutional investors have recently modified their holdings of the business. Gladius Capital Management LP acquired a new stake in Enhabit during the 4th quarter worth about $42,000. Allspring Global Investments Holdings LLC bought a new stake in Enhabit during the 1st quarter valued at $44,000. Quantbot Technologies LP bought a new stake in shares of Enhabit during the third quarter worth about $73,000. ProShare Advisors LLC acquired a new position in Enhabit during the 1st quarter valued at about $118,000. Finally, Family Firm Inc. purchased a new position in shares of Enhabit during the first quarter valued at approximately $124,000.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.